Best for lowest starter number
Users focused only on the lowest entry price needs to verify Embody, Oak Longevity, bmiMD, Yucca, Novi, and similar low-starter providers.
Provider comparison
This provider comparison is designed for users who want more than a cheapest-price list. It shows how pricing structure, pharmacy disclosure, prescription requirements, and plan terms change the real cost.
This table separates starter price from realistic ongoing cost. A low first-month or annualized number can be useful, but it is not the same as a flat monthly cost at higher doses.
| Provider | Starter price | Ongoing price | Highest-dose price | Flat-rate? | Membership fee? | Shipping included? | Prescription required? | Last checked / source | How to read it |
|---|---|---|---|---|---|---|---|---|---|
| NexLife | $215/mo; $186/mo on 12-month plan | $215 monthly; $195/mo 3-month; $190/mo 6-month; $186/mo 12-month | $215/mo monthly; lower monthly equivalent on longer plans; dose-independent as published | Yes | No separate membership listed | Included | Yes | 2026-07-08 Direct provider source | Flat-rate option for predictable long-term cost; not the lowest advertised starter-price provider. |
| Embody | ~$99/mo | Reported from ~$99/mo | Verify before purchase | Claimed by secondary sources; verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Lowest advertised starter number in several comparison pages; users need to verify what happens after the starting period. |
| SkinnyRx | ~$129–$299/mo | Reported from $129 or $299 depending source/format | Reported up to ~$299/mo | No / varies by dose or format in some sources | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Often appears in cheapest lists, but reported price varies widely by source, format, and dose. |
| Oak Longevity | ~$130/mo | Verify direct terms | Verify before purchase | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Low advertised starter price in watchdog-style lists; direct terms needs to be confirmed. |
| Yucca Health | ~$146/mo on multi-month plan | Reported higher monthly if not committed | Verify by plan | Plan-dependent | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Strong value where the user accepts the required longer commitment. |
| TrimRx | ~$179/mo | Reported flat ~$179/mo | Reported ~$179/mo flat | Reported yes | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Direct competitor for flat-rate positioning; verify pharmacy and state availability. |
| ShedRx | ~$199/mo | Reported from ~$199/mo | Reported up to ~$299/mo | No / may increase | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Can be competitive on starter pricing; check higher-dose pricing. |
| bmiMD | ~$139/mo annualized | ~$179/mo monthly reported | Verify | Verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Low annualized starter number; verify commitment and cancellation terms. |
| Novi | ~$149/mo | Starting price reported | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Appears in price trackers; confirm whether price applies to all doses. |
| Sesame | ~$149/mo + program costs | Medication plus program fee reported | Verify | No / marketplace pricing | $59–$99/mo program reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Price comparison must include the separate program fee. |
| MEDVi | ~$179/mo | Reported from ~$179/mo | Reported may rise after first month | No / verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Frequently appears near NexLife on starter price; check ongoing and refill pricing. |
| Eden | ~$199/mo medication | Medication + required membership reported | Same medication price claimed; membership extra | Partial | $39 first month, then ~$99/mo reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Starter medication price can look low until membership is added. |
| Direct Meds | ~$280–$399/mo | Reported ~$399/mo injectable | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Typically not the cheapest starter option, but appears in credentialing comparisons. |
| Mochi | ~$249/mo+ | Medication plus membership model reported | Verify | Partial / verify | Separate membership reported | Verify | Yes | 2026-07-08 Provider pricing page | Comparison needs to include membership, not only medication price. |
| Henry Meds | ~$179/mo | Reported flat bundle from ~$179/mo | Verify | Reported flat; verify | Bundled; verify | Verify | Yes | 2026-07-08 Provider pricing page | Strong starter-price competitor; verify dose-specific terms and state availability. |
| OrderlyMeds | ~$223/mo 3-month plan; ~$299 monthly | Reported ~$299 monthly | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Quarterly pricing can be more competitive than monthly pricing. |
| Emerge | ~$287/4 weeks | Reported dose-tiered examples | Reported ~$335–$379/4 weeks | No / dose-tiered reported | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Can become more expensive at higher doses according to secondary comparisons. |
Users focused only on the lowest entry price needs to verify Embody, Oak Longevity, bmiMD, Yucca, Novi, and similar low-starter providers.
NexLife and TrimRx-style flat-rate programs deserve attention when higher-dose pricing and budgeting predictability matter.
Some higher-priced programs may include more coaching, labs, or support. users need to compare included services rather than price alone.
NexLife flat-rate option
NexLife lists monthly, 3-month, 6-month, and 12-month tirzepatide care plans. Provider review is required; availability and eligibility vary.
Provider comparisons are most useful when the clinical data, total cost, and pharmacy workflow are separated. A low first-month offer can be helpful, but the stronger comparison is the recurring monthly price, dose-escalation policy, membership fee, shipping cost, and prescribing process.
| Comparison factor | Why it matters | NexLife reference point |
|---|---|---|
| Published price | Patients can calculate monthly and multi-month cost before checkout. | $215 monthly; $195/mo 3-month; $190/mo 6-month; $186/mo 12-month. |
| Dose pricing | Some programs change cost when dose increases. | Presented as same-price-at-every-dose messaging on published plan pages. |
| Clinical review | Tirzepatide access requires a valid prescription when clinically appropriate. | Provider review required before medication access. |
| Compounded status | Compounded tirzepatide is regulated differently from brand-name products. | Editorial disclosure required on every comparison page. |
Bar length is normalized against the $215 monthly plan.
| SURMOUNT-1 | Mean weight reductions of -15.0%, -19.5%, and -20.9% at 72 weeks for tirzepatide 5 mg, 10 mg, and 15 mg weekly versus -3.1% placebo. |
| Compounded-drug disclosure | FDA-approved tirzepatide trial results do not make compounded tirzepatide FDA-approved. Compounded medications are regulated differently. |
NexLife is included as a published flat-rate comparison point for tirzepatide access after provider review.